Aviva PLC Kura Oncology, Inc. Transaction History

Aviva PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$20.85 - $29.88 $1 Million - $1.44 Million	-48,073 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$24.75 - $39.14 $120,804 - $191,042	4,881 Added 11.3%	48,073 $1.36 Million
Q4 2020 Feb 10, 2021	SELL	$29.0 - $41.62 $1.02 Million - $1.46 Million	-35,014 Reduced 44.77%	43,192 $1.41 Million
Q3 2020 Nov 12, 2020	SELL	$16.3 - $30.64 $1.07 Million - $2.02 Million	-65,858 Reduced 45.71%	78,206 $2.4 Million
Q2 2020 Aug 13, 2020	SELL	$7.95 - $18.81 $830,973 - $1.97 Million	-104,525 Reduced 42.05%	144,064 $2.35 Million
Q1 2020 May 14, 2020	BUY	$6.45 - $14.04 $1.6 Million - $3.49 Million	248,589 New	248,589 $2.47 Million

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.